Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Cell Impact

0.05 SEK-7.97 %26/8 16:53
Less than 1K followers

CI

First North Stockholm

Industrial Goods & Services

Industrials

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
-7.97 %
-7.08 %
-58.60 %
-61.47 %
-53.20 %
-48.36 %
-98.88 %
-99.90 %
-97.75 %

Cell Impact is a technology company focused on the industrial sector. The company produces and supplies flow plates and production technology to fuel cell manufacturers. The company has developed and patented a method for high-speed forming (adiabatic high-velocity forming) that makes it possible to manufacture flow plates with high energy density. The largest market is found in the transportation sector, with a focus on warehouse vehicles, buses and light trucks as well as passenger cars.

Read more
Market cap
66.14M SEK
Turnover
151.2K SEK
Revenue
5.57M
EBIT %
-2,296.59 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
6/11
2026

Interim report Q3'26

12/2
2027

Annual report '26

22/4
2027

General meeting '27

Press release2026-08-24 13:34

Analyst Group: Analyst Group kommenterar utfallet i Cell Impacts företrädesemission

Cell Impact
Regulatory press release2026-08-21 18:42

Cell Impact announces outcome of the company's rights issue

Cell Impact
Regulatory press release2026-08-21 18:42

Cell Impact offentliggör utfall i bolagets företrädesemission

Cell Impact

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-08-19 08:37

Analyst Group: Aktieanalys på Cell Impact - Order bekräftar att pipelinen mognar

Cell Impact
Regulatory press release2026-08-19 08:03

The last day for subscription in Cell Impact AB's ongoing rights issue of units is tomorrow, 20 August 2026

Cell Impact
Regulatory press release2026-08-19 08:03

Sista dag för teckning i Cell Impact AB:s pågående företrädesemission av units är imorgon den 20 augusti 2026

Cell Impact
Regulatory press release2026-08-17 10:20

Sista dag för handel med uniträtter i Cell Impacts företrädesemission

Cell Impact
Regulatory press release2026-08-17 10:20

Last day of trading in unit rights in Cell Impact's rights issue

Cell Impact
Regulatory press release2026-08-14 11:28

Cell Impacts VD, Daniel Vallin, har genomfört en VD-intervju med Mangold Insight

Cell Impact
Regulatory press release2026-08-14 11:28

Cell Impact's CEO, Daniel Vallin, has conducted a CEO interview with Mangold Insight

Cell Impact
Regulatory press release2026-08-13 14:07

Members of the company's Board of Directors and management subscribe for units in Cell Impact's ongoing rights issue of units

Cell Impact
Regulatory press release2026-08-13 14:07

Medlemmar i bolagets styrelse och ledning tecknar units i Cell Impacts pågående företrädesemissionen av units

Cell Impact
Press release2026-08-07 13:37

Nyemissioner.se: Läs om Cell Impact som genomför en företrädesemission om 53,6 MSEK

Cell Impact
Third party research2026-08-06 09:47

Cell Impact: Q2 2026 - Analysguiden

Cell Impact förbättrade resultatet i Q2 samtidigt som en order om 5,3 MSEK visar att ett kundprojekt har nått reguljär produktion. Den låga omsättningen och ansträngda likviditeten innebär dock att investeringscaset fortsatt avgörs av emissionsutfallet...

Cell Impact
Press release2026-08-06 09:30

Analysguiden: ANALYS: Cell Impact Q2 2026

Cell Impact
Regulatory press release2026-08-06 08:30

Teckningsperioden i Cell Impacts företrädesemission av units inleds idag

Cell Impact
Regulatory press release2026-08-06 08:30

The subscription period in Cell Impact's rights issue of units starts today

Cell Impact
Press release2026-08-05 16:50

Analyst Group: Analyst Group kommenterar Cell Impacts Q2-rapport

Cell Impact
Regulatory press release2026-08-05 08:03

Cell Impact Q2 2026: Progress continues despite prolonged lead times

Cell Impact
Regulatory press release2026-08-05 08:03

Cell Impact Q2 2026: Fortsatta framsteg trots utdragna ledtider

Cell Impact